Also in this playlist...
This transcript is automatically generated
It seems like not much can take the wind out of Wall Street's sales these days US stocks edging higher in midday trading despite weak earnings for Merck.
The pharmaceutical giant posted a 35%.
Drop in profits for the third quarter.
The company ramps up its research and development department while suffering from a slow down its sales of that popular allergy medicine Cingular.
Still the SP 500 is coming off its 31 record close this year.
And -- four straight weeks of gains while the Dallas it's only a couple of points below its all time record close so what should you expect for the coming week.
I think we are in their record this week I think hedge funds have missed a substantial portion of this move -- yelling just loves those pretty impressive so I'm actually expecting her to add to accommodation going all the way in the -- to fourteen.
-- more economic stimulus from the Federal Reserve may be exactly what the markets need to go higher.
-- economic data continues to leave a sour taste and investors now.
Latest number pending home sales which slipped for the fourth month in a row to its lowest level of the year and the steepest decline in almost two and a half years.
For more log on to foxbusiness.com.
In New York I'm David --
Filter by section